Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 6 , Pages 383-390 , July 2009

A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III

  • S. Kalkan Ucar

      Affiliations

    • Ege University Medical Faculty, Department of Pediatric Endocrinology and Metabolism, Bornova, Izmir, Turkey
    • Corresponding Author InformationCorresponding author. Ege University Medical Faculty, Department of Pediatric Endocrinology and Metabolism, 124 Sok, No. 5/25, Bornova, Izmir, Turkey. Tel.: +90 2323901239; fax: +90 2323886366.
    • ,
  • M. Coker

      Affiliations

    • Ege University Medical Faculty, Department of Pediatric Endocrinology and Metabolism, Bornova, Izmir, Turkey
    • ,
  • E. Sözmen

      Affiliations

    • Ege University Medical Faculty, Department of Biochemistry, Bornova, Izmir, Turkey
    • ,
  • D. Goksen Simsek

      Affiliations

    • Ege University Medical Faculty, Department of Pediatric Endocrinology and Metabolism, Bornova, Izmir, Turkey
    • ,
  • S. Darcan

      Affiliations

    • Ege University Medical Faculty, Department of Pediatric Endocrinology and Metabolism, Bornova, Izmir, Turkey

Received 25 April 2008 ,Revised 8 August 2008 ,Accepted 1 September 2008.

References 

  1. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 1992;12(11):1336–1345
  2. Wiegman A, de Groot E, Hutten BA, Rodenburg J, Gort J, Bakker HD, et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet. 2004;363:369–370
  3. Lee PJ. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis. 1994;110:95–100
  4. Ubels FL, Rake JP, Slaets JPJ, Smit GPA, Smit AJ. Is glycogen storage disease 1a associated with atherosclerosis?. Eur J Pediatr. 2002;161(Suppl. 1):S62–S64
  5. Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science. 1993;262:580–583
  6. Shen JJ, Chen YT. Molecular characterization of glycogen storage disease type III. Curr Mol Med. 2002;2:167–175
  7. Smit GPA, Fernandes J, Leonard JV, Mathews EE, Moses SW, Odievre M, et al. The long-term outcome of patients with glycogen storage diseases. J Inherit Metab Dis. 1990;13:411–418
  8. Hershkovitz E, Donald A, Mullen M, Lee PJ, Leonard JV. Blood lipids and endothelial function in glycogen storage disease type III. J Inherit Metab Dis. 1999;22:891–898
  9. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(Suppl. 6A):9S–16S
  10. Rake JP, Visser G, Smit PA. Disorder of carbohydrate and glycogen metabolism. In:  Blau N,  Hoffmann JL,  Clarke TR editor. Physician's guide to the treatment and follow-up of metabolic diseases. 3rd ed.. Berlin, Heidelberg, New York: Springer; 2006;p. 173
  11. Zöllner N, Kirsch K. Uber die quantitative Bestimmung von Lipoiden (Mikromethode) mittels der vielen natürlichen Lipoiden (allen bekannten Plasmalipoiden) gemeinsamen Sulfophosphovanillin-Reaktion. Z Gesamte Exp Med. 1962;135:545–561
  12. Stupans I, Kirlich A, Tuck KL, Hayball PJ. Comparison of radical scavenging effect, inhibition of microsomal oxygen free radical generation and serum lipoprotein oxidation of several natural antioxidants. J Agric Food Chem. 2002;50:2464–2469
  13. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26:1231–1237
  14. Yıldırım HK, Akçay YD, Güvenç U, Altındişli A, Sözmen EY. Antioxidant activities of organic grape, pomace, juice, must, wine and their correlation with phenolic content. Int J Food Sci Technol. 2005;40:133–142
  15. Pulido R, Bravo L, Saura-Calixto F. Antioxidant activity of dietary polyphenols as determined by a modified FRAP assay. J Agric Food Chem. 2000;48:3396–3402
  16. Eckerson HW, Wyte C, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet. 1983;35:1126–1138
  17. Liau LS, Lee BL, New AL, Ong CN. Determination of plasma ascorbic acid by high-performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr. 1993;612:63–70
  18. Erhardt JG, Heinrich F, Biesalski HK. Determination of retinol and antioxidant vitamins and homocysteine in skin puncture blood. Int J Vitam Nutr Res. 1999;69:309–314
  19. Sözmen EY, Sözmen B, Girgin FK, Delen Y, Azarsız E, Erdener D, et al. Antioxidant enzymes and paraoxonase show co-activity in preserving LDL from oxidation. Clin Exp Med. 2001;1:195–199
  20. Whicker JT, Ritchie RF, Johnson AM. New international reference preparation for proteins in human serum (RPPHS). Clin Chem. 1994;40:934–938
  21. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschütter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med. 2002;33:103–110
  22. Nguyen AD, Pan CJ, Weinstein DA, Chou JY. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Mol Genet Metab. 2006;89(3):233–238
  23. Geberhiwot T, Alger S, McKiernan P, Packard C, Caslake M, Elias E, et al. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX. J Inherit Metab Dis. 2007;30(3):406
  24. Sorensen KE, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield LE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolaemia and is related to the lipoprotein(a) level. J Clin Invest. 1994;93:50–57
  25. Vertuani S, Angusti A, Manfredini S. The antioxidants and proantioxidants network: an overview. Curr Pharm Des. 2004;10:1677–1694
  26. Smit GPA, Rake JP, Akman HO, DiMauro S. The glycogen storage diseases and related disorders. In: Fernandes , Saudubray , van den Berghe , Walter  editor. Inborn metabolic diseases diagnosis and treatment. 4th ed.. Berlin: Springer; 2006;p. 102–119
  27. Halliwell B, Gutteridge JMC. Antioxidant defences. In: Free radicals and medicine. 2nd ed.. Oxford science publication. Oxford University Press; 2000;p. 195–197
  28. Halliwell B, Gutteridge JMC. Antioxidant defences. In: Free radicals and medicine. 2nd ed.. Oxford science publication. Oxford University Press; 2000;p. 203
  29. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidative defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1983;78:6858–6862
  30. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis. 2000;148:131–139
  31. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med. 1993;14:615–631

PII: S0939-4753(08)00186-5

doi: 10.1016/j.numecd.2008.09.005

Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 6 , Pages 383-390 , July 2009

Article Tools

* Image Usage & Resolution